Freelance Science Writer & Journalist
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Got a Question for RJ Mackenzie?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 612
News
Alzheimer’s Drug Gets Full FDA Approval Despite Safety Concerns
The FDA has this week converted the accelerated approval of the Alzheimer’s disease drug lecanemab to a traditional approval. However, concerns regarding side effects weighed against limited clinical benefits raise concerns surrounding its use.
News
Feral Mink Brains Suggest That the Effects of Domestication Can Be Reversed
In a highly unexpected defiance of evolutionary biology, feral populations of the American mink have been shown to reverse key changes to their brain size that occur during domestication. The study reaffirms the amazingly plastic nature of the animal brain, even in the face of many generations of selective breeding.
News
Depression After a TBI May Be a Distinct Condition
A new study suggests that depression developing in the aftermath of a traumatic brain injury (TBI) should be characterized differently from classical major depressive disorder (MDD).
Article
Aspartame’s New Status as a “Possible Carcinogen”: What Does It Mean?
Last week, conclusions from an upcoming report by the International Agency for Research on Cancer (IARC) were leaked. Reuters reported that the IARC was set to list the sweetener aspartame as a “possible carcinogen”. What does aspartame’s new designation mean, and should it alter your food choices?
Article
The Pulse: Psychedelic News From Technology Networks Issue 5
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
News
Cotton Genome Sequence Could Boost Global Agriculture
Out of the 50 recognized species of cotton, just 4 are useful for the textile industry. A new study led by an informatics team at DePaul University has mapped out the genome of one of these vital cotton species to give a full account of how wild cotton was domesticated.
News
Common Form of Hair Loss Could Be Reversed by Targeting Aged Skin Pigment Cells
A research group led by the University of California, Irvine has revealed the mechanisms behind the rampant hair growth observed in skin moles, or nevi. The team has shown that the process is triggered by aging pigment cells.
News
Brain Data Analysis Predicts Chart Hit Songs With Near-Perfect Accuracy
Anticipating chart-topping songs has always been challenging. However, scientists have leveraged machine learning (ML) coupled with high-frequency neurophysiological data to significantly enhance the accuracy of hit song predictions.
News
Brain System That Creates Optical Illusions Identified
In an illuminating study, scientists have unveiled that a number of visual illusions are predominantly attributed to constraints in the operations of our eyes and visual neurons, as opposed to more intricate cognitive functions. T
News
Multiple Psychedelic Drugs Can Reopen the Critical Period for Socializing in Mice
A new study conducted at the lab in mice suggests that multiple psychedelic drugs are capable of reopening "critical periods" in the brain for durations stretching from just a couple of days through to a full month.
Advertisement
